CT45A10: Interleukin-2 Receptor Alpha Chain Subunit and Cancer Development

Target Name: CT45A10

NCBI ID: G102723631

CT45A10

CT45A10: Interleukin-2 Receptor Alpha Chain Subunit and Cancer Development

CT45A10 is a protein that is expressed in a variety of tissues throughout the body, including the lungs, liver, and bones. It is also highly expressed in cancer cells. The protein is derived from the extracellular domain of the interleukin-2 receptor alpha chain, which is a protein that is expressed in a variety of cell types throughout the body.

The alpha chain of the interleukin-2 receptor is composed of four subunits, which are the alpha chain subunit 1 (CT45A1), alpha chain subunit 2 (CT45A2), alpha chain subunit 3 (CT45A3), and alpha chain subunit 4 (CT45A4). The alpha chain subunits are responsible for the various functions of the interleukin-2 receptor, including cell signaling and survival.

CT45A10 is a 21-kDa protein that is expressed in a variety of tissues throughout the body. It is highly expressed in cancer cells, and has been shown to be involved in the development and progression of a variety of cancers.

One of the main functions of CT45A10 is its role in cell signaling. The alpha chain subunits of the interleukin-2 receptor are involved in the regulation of cell signaling pathways, including the T cell signaling pathway. This pathway is important for the development and regulation of immune responses, and is a key target for cancer cells.

In addition to its role in cell signaling, CT45A10 is also involved in the regulation of cell survival. The alpha chain subunits of the interleukin-2 receptor are involved in the regulation of cell apoptosis, which is the process by which cells die and are removed from the body. This regulation is important for the control of cell growth and division, and is a key target for cancer cells.

The alpha chain subunits of the interleukin-2 receptor are also involved in the regulation of cell signaling pathways that are important for the development and progression of autoimmune diseases. For example, the alpha chain subunit 1 of the interleukin-2 receptor is involved in the regulation of the development and function of regulatory T cells, which are a type of immune cell that help to regulate and control other immune cells.

In conclusion, CT45A10 is a protein that is expressed in a variety of tissues throughout the body, including the lungs, liver, and bones. It is highly expressed in cancer cells and is involved in the development and progression of a variety of cancers. The alpha chain subunits of the interleukin-2 receptor are responsible for the various functions of the receptor, including cell signaling and survival, and are a key target for cancer cells. Further research is needed to fully understand the role of CT45A10 in cancer progression and the development of autoimmune diseases.

Protein Name: Cancer/testis Antigen Family 45 Member A10

The "CT45A10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CT45A10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets